LESLEE ROSAS: Open Payments
NPI 1124665161 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 41 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $233 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| ABBVIE INC. | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
Products named: FARXIGA, Kerendia, VRAYLAR, TRINTELLIX, REXULTI, VOQUEZNA, Wegovy, QULIPTA.
Industry payments across TX — which companies pay providers there.
